Cardeus Pharmaceuticals

Cardeus Pharmaceuticals is a private California-based pharmaceutical startup formed in 2011 to develop, manufacture, and commercialize selected in-licensed Astellas compounds outside Japan. Publicly available information indicates the company was seed financed by Mitsui & Co. Global Investment and led by founding CEO Karen J. Brunke. Cardeus appears to have focused on small-molecule assets spanning cardiovascular, pain, and neuroscience-related opportunities rather than operating a broad proprietary discovery platform. The company has maintained only a limited public footprint, and there is no clear evidence of advanced clinical-stage development or commercialization under the Cardeus name. Available third-party sources still list the company as alive/private, but recent operating details are sparse.